Technical Analysis for ATH - Alterity Therapeutics Limited
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Boomer Buy Setup | Bullish Swing Setup | 0.00% | |
| Volume Surge | Other | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Boomer Buy Setup | Bullish Swing Setup | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Boomer Buy Setup | Bullish Swing Setup | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% |
| Alert | Time |
|---|---|
| 10x Volume Pace | about 12 hours ago |
| 5x Volume Pace | about 12 hours ago |
| 3x Volume Pace | about 12 hours ago |
| 2x Volume Pace | about 12 hours ago |
| 1.5x Volume Pace | about 12 hours ago |
Get a Trading Sidekick!
Alterity Therapeutics Limited Description
Alterity Therapeutics Limited, formerly Prana Biotechnology Limited, is a development-stage medical biotechnology company. The Company is engaged in the research and development of therapeutic drugs designed to treat the underlying cause of degeneration of the brain focusing on Alzheimer's disease, Huntington disease, Parkinson's disease and other neurological disorders. The Company's lead product candidates are PBT2 and PBT434. The Company's lead drug candidate PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. The Company also has advanced a drug candidate for Parkinson's disease and other movement disorders (PBT434) and brain cancer (PBT519), which are in pre-clinical toxicology testing. Its other applications for its therapies include certain cancers, age-related macular degeneration, Motor Neuron disease, Creutzfeldt-Jakob disease (the human variant of Mad Cow disease), and a range of orphan neurodegenerative disorders.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Disease Diseases Cancer Drugs Biology Cancers Disorders Geriatrics Neuroscience Psychiatric Diagnosis Alzheimer's Disease Brain Cancer Macular Degeneration Neurological Disorders Parkinson Degenerative Disease Medical Biotechnology Neurodegeneration Parkinson's Disease
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 0.0085 |
| 52 Week Low | 0.002 |
| Average Volume | 4,540,861 |
| 200-Day Moving Average | 0.004 |
| 50-Day Moving Average | 0.003 |
| 20-Day Moving Average | 0.003 |
| 10-Day Moving Average | 0.003 |
| Average True Range | 0.001 |
| RSI (14) | 50.00 |
| ADX | 31.22 |
| +DI | 32.353 |
| -DI | 17.647 |
| Chandelier Exit (Long, 3 ATRs) | 0.002 |
| Chandelier Exit (Short, 3 ATRs) | 0.004 |
| Upper Bollinger Bands | 0.004 |
| Lower Bollinger Band | 0.003 |
| Percent B (%b) | 0.42 |
| BandWidth | 38.710 |
| MACD Line | 0.000 |
| MACD Signal Line | 0.000 |
| MACD Histogram | 0.0 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.003 | ||||
| Resistance 3 (R3) | 0.003 | 0.003 | 0.003 | ||
| Resistance 2 (R2) | 0.003 | 0.003 | 0.003 | 0.003 | |
| Resistance 1 (R1) | 0.003 | 0.003 | 0.003 | 0.003 | 0.003 |
| Pivot Point | 0.003 | 0.003 | 0.003 | 0.003 | 0.003 |
| Support 1 (S1) | 0.003 | 0.003 | 0.003 | 0.003 | 0.003 |
| Support 2 (S2) | 0.003 | 0.003 | 0.003 | 0.003 | |
| Support 3 (S3) | 0.003 | 0.003 | 0.003 | ||
| Support 4 (S4) | 0.003 |
